
Sign up to save your podcasts
Or
Kevin Lee, CEO of Bicycle Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Bicycle Therapeutics is working on developing a new class of medicines, called Bicycles, for diseases that are underserved by existing therapeutics.
5
77 ratings
Kevin Lee, CEO of Bicycle Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Bicycle Therapeutics is working on developing a new class of medicines, called Bicycles, for diseases that are underserved by existing therapeutics.
1,040 Listeners
29 Listeners
275 Listeners
309 Listeners
340 Listeners
386 Listeners
121 Listeners
317 Listeners
197 Listeners
84 Listeners
88 Listeners
422 Listeners
144 Listeners
18 Listeners
70 Listeners